Insider holders · CIK 0001674416
CRISPR Therapeutics AG · CRSP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals (Europe) Ltd10% Owner | 5,380,940 | — | 5,380,940 | Dec 28, 2018 · 4:34 pm EST | Form 4 |
| Pharmaceuticals Inc / Ma Vertex10% Owner | 5,380,940 | — | 5,380,940 | Dec 28, 2018 · 4:34 pm EST | Form 4 |
| Bayer Global Investments B.V.10% Owner | 5,105,330 | 75,945 | 5,181,275 | Jan 30, 2018 · 2:21 pm EST | Form 4 |
| Aktiengesellschaft Bayer10% Owner | 5,105,330 | 75,945 | 5,181,275 | Jan 30, 2018 · 2:21 pm EST | Form 4 |
| CELGENE CORP10% Owner | — | 3,722,534 | 3,722,534 | Dec 7, 2017 · 9:57 am EST | Form 4 |
| Simeon GeorgeDirector | — | 3,220,627 | 3,220,627 | Oct 26, 2016 · 5:51 pm EDT | Form 4 |
| GLAXOSMITHKLINE PLC10% Owner | — | 3,220,627 | 3,220,627 | Oct 26, 2016 · 5:49 pm EDT | Form 4 |
| Kurt Von EmsterDirector | — | 1,171,268 | 1,171,268 | Jan 18, 2019 · 4:32 pm EST | Form 4/A |
| Sven Ante LundbergChief Scientific Officer | 505,217 | 505,617 | 1,010,834 | Feb 10, 2017 · 2:16 pm EST | Form 4 |
| Rodger NovakPresident | 948,007 | — | 948,007 | Mar 5, 2019 · 5:59 pm EST | Form 4 |
| Hadley Harbor Master Investors (Cayman) L.P.10% Owner | 744,380 | — | 744,380 | Oct 24, 2016 · 2:58 pm EDT | Form 4 |
| Bradley J Bolzon Ph.D.Director | 34,745 | 640,014 | 674,759 | May 17, 2018 · 5:15 pm EDT | Form 4 |
| Thomas WoiwodeDirector | 5,629 | 640,014 | 645,643 | May 17, 2018 · 5:11 pm EDT | Form 4 |
| Samarth KulkarniChief Executive Officer | 166,542 | — | 166,542 | Mar 5, 2019 · 5:57 pm EST | Form 4 |
| Versant Side Fund IV, L.P.10% Owner | — | 117,173 | 117,173 | Apr 24, 2018 · 7:44 pm EDT | Form 4 |
| Versant Venture Capital IV, L.P.10% Owner | — | 117,173 | 117,173 | Apr 24, 2018 · 7:44 pm EDT | Form 4 |
| Versant Ventures IV, LLC10% Owner | — | 117,173 | 117,173 | Apr 24, 2018 · 7:44 pm EDT | Form 4 |
| Versant Ventures V, LLC10% Owner | — | 115,645 | 115,645 | Apr 26, 2018 · 4:44 pm EDT | Form 4 |
| Versant Venture Capital V (Canada), LP10% Owner | — | 115,645 | 115,645 | Apr 26, 2018 · 4:44 pm EDT | Form 4 |
| Versant Ophthalmic Affiliates I, L.P.10% Owner | — | 115,645 | 115,645 | Apr 26, 2018 · 4:44 pm EDT | Form 4 |
| Versant Venture Capital V, L.P.10% Owner | — | 115,645 | 115,645 | Apr 26, 2018 · 4:44 pm EDT | Form 4 |
| Versant Affiliates Fund V, L.P.10% Owner | — | 115,645 | 115,645 | Apr 26, 2018 · 4:44 pm EDT | Form 4 |
| James R. KasingerGeneral Counsel and Secretary | 94,784 | — | 94,784 | Sep 24, 2026 · 5:35 pm EDT | Form 4 |
| N Anthony ColesDirector | — | 70,000 | 70,000 | Oct 26, 2016 · 6:28 pm EDT | Form 4 |
| Tony W HoSee Remarks | 32,869 | — | 32,869 | Mar 7, 2019 · 4:12 pm EST | Form 4 |
| Tyler Dylan-HydeChief Legal Officer | 25,204 | — | 25,204 | Jan 18, 2018 · 5:38 pm EST | Form 4 |
| Lawrence Otto KleinChief Business Officer | 20,000 | — | 20,000 | Jan 3, 2019 · 4:32 pm EST | Form 4 |
| Ali BehbahaniDirector | 16,637 | 29 | 16,666 | Sep 21, 2026 · 6:40 pm EDT | Form 4 |
| Raju PrasadChief Financial Officer | 14,815 | — | 14,815 | Aug 11, 2026 · 5:35 pm EDT | Form 4 |
| Versant Ventures V (Canada), L.P.10% Owner | — | 0 | 0 | Sep 7, 2017 · 9:35 pm EDT | Form 4 |
| Pablo J CagnoniDirector | 0 | — | 0 | Jul 5, 2018 · 6:25 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.